A citation-based method for searching scientific literature

Junxiang Luo, Yongming Qu, Qianyi Zhang, Annette M Chang, Scott J Jacober. J Diabetes Sci Technol 2018
Times Cited: 2







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


4
100

Rate of hypoglycemia in insulin-treated patients with type 2 diabetes can be predicted from glycemic variability data.
Yongming Qu, Scott J Jacober, Qianyi Zhang, Linda L Wolka, J Hans DeVries. Diabetes Technol Ther 2012
83
50

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
50

Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis.
Despoina Vasilakou, Thomas Karagiannis, Eleni Athanasiadou, Maria Mainou, Aris Liakos, Eleni Bekiari, Maria Sarigianni, David R Matthews, Apostolos Tsapas. Ann Intern Med 2013
510
50

Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial.
R R Henry, A V Murray, M H Marmolejo, D Hennicken, A Ptaszynska, J F List. Int J Clin Pract 2012
207
50


Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study.
Rimei Nishimura, Yuko Tanaka, Kazuki Koiwai, Kohei Inoue, Thomas Hach, Afshin Salsali, Søren S Lund, Uli C Broedl. Cardiovasc Diabetol 2015
72
50



Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial.
Clifford J Bailey, Jorge L Gross, Delphine Hennicken, Nayyar Iqbal, Traci A Mansfield, James F List. BMC Med 2013
199
50

GlyCulator: a glycemic variability calculation tool for continuous glucose monitoring data.
Dorota Czerwoniuk, Wojciech Fendler, Lukasz Walenciak, Wojciech Mlynarski. J Diabetes Sci Technol 2011
43
50

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
50

Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial.
Michael A Nauck, Stefano Del Prato, Juris J Meier, Santiago Durán-García, Katja Rohwedder, Martina Elze, Shamik J Parikh. Diabetes Care 2011
363
50

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.
Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close. Diabetes Care 2019
199
50


Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetes Care 2018
991
50

Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study.
B Guerci, L Monnier, P Serusclat, C Petit, P Valensi, D Huet, D Raccah, C Colette, S Quéré, S Dejager. Diabetes Metab 2012
53
50

Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program.
Thomas Danne, Bertrand Cariou, John B Buse, Satish K Garg, Julio Rosenstock, Phillip Banks, Jake A Kushner, Darren K McGuire, Anne L Peters, Sangeeta Sawhney,[...]. Diabetes Care 2019
30
50

Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes.
Ralph A DeFronzo, Marcus Hompesch, Sreeneeranj Kasichayanula, Xiaoni Liu, Ying Hong, Marc Pfister, Linda A Morrow, Bruce R Leslie, David W Boulton, Agatha Ching,[...]. Diabetes Care 2013
165
50

Mean amplitude of glycemic excursions, a measure of diabetic instability.
F J Service, G D Molnar, J W Rosevear, E Ackerman, L C Gatewood, W F Taylor. Diabetes 1970
823
50

The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs.
Chang-Liang Zhang, Megumi Katoh, Tadao Shibasaki, Kohtaro Minami, Yasuhiro Sunaga, Harumi Takahashi, Norihide Yokoi, Masahiro Iwasaki, Takashi Miki, Susumu Seino. Science 2009
158
50

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
50

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
50

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile.
Richard M Bergenstal, Andrew J Ahmann, Timothy Bailey, Roy W Beck, Joan Bissen, Bruce Buckingham, Larry Deeb, Robert H Dolin, Satish K Garg, Robin Goland,[...]. J Diabetes Sci Technol 2013
64
50

International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
589
50

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
50


Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes.
Jingyi Lu, Xiaojing Ma, Jian Zhou, Lei Zhang, Yifei Mo, Lingwen Ying, Wei Lu, Wei Zhu, Yuqian Bao, Robert A Vigersky,[...]. Diabetes Care 2018
140
50



The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
Robert A Vigersky, Chantal McMahon. Diabetes Technol Ther 2019
109
50


Cardiovascular disease in diabetes.
Zachary T Bloomgarden. Diabetes Care 2010
10
50


Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial.
Robert R Henry, Poul Strange, Rong Zhou, Jeremy Pettus, Leon Shi, Sergey B Zhuplatov, Traci Mansfield, David Klein, Arie Katz. Diabetes Technol Ther 2018
21
50

Hypoglycaemia and QT interval prolongation: Detection by simultaneous Holter and continuous glucose monitoring.
Angela S Lee, Belinda A Brooks, Lisa Simmons, Michael J Kilborn, Jencia Wong, Stephen M Twigg, Dennis K Yue. Diabetes Res Clin Pract 2016
13
50

Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients.
Alessandra Di Flaviani, Fabiana Picconi, Paola Di Stefano, Ilaria Giordani, Ilaria Malandrucco, Paola Maggio, Paola Palazzo, Fabrizio Sgreccia, Carlo Peraldo, Fabrizio Farina,[...]. Diabetes Care 2011
112
50

Effects of sitagliptin on 24-h glycemic changes in Japanese patients with type 2 diabetes assessed using continuous glucose monitoring.
Yutaka Mori, Yukiko Taniguchi, Kenichi Matsuura, Kazunori Sezaki, Junichi Yokoyama, Kazunori Utsunomiya. Diabetes Technol Ther 2011
22
50

Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations.
Raffaele Marfella, Michelangela Barbieri, Rodolfo Grella, Maria Rosaria Rizzo, Giovanni Francesco Nicoletti, Giuseppe Paolisso. J Diabetes Complications 2010
74
50

Coronary microvascular dysfunction in diabetes mellitus.
Aleksandar Kibel, Kristina Selthofer-Relatic, Ines Drenjancevic, Tatjana Bacun, Ivica Bosnjak, Dijana Kibel, Mario Gros. J Int Med Res 2017
47
50

Effect of Dulaglutide Versus Liraglutide on Glucose Variability, Oxidative Stress, and Endothelial Function in Type 2 Diabetes: A Prospective Study.
Hiroe Nagaike, Makoto Ohara, Yo Kohata, Munenori Hiromura, Masako Tomoyasu, Michiya Takada, Takeshi Yamamoto, Toshiyuki Hayashi, Tomoyasu Fukui, Tsutomu Hirano. Diabetes Ther 2019
7
50

Continuous glucose monitoring defined glucose variability is associated with cardiovascular autonomic neuropathy in type 1 diabetes.
Ji Eun Jun, Seung-Eun Lee, You-Bin Lee, Ji Yeon Ahn, Gyuri Kim, Kyu Yeon Hur, Moon-Kyu Lee, Sang-Man Jin, Jae Hyeon Kim. Diabetes Metab Res Rev 2019
12
50

Macro- and microvascular endothelial dysfunction in diabetes.
Yi Shi, Paul M Vanhoutte. J Diabetes 2017
153
50

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn,[...]. N Engl J Med 2015
50


Simultaneous GLP-1 and insulin administration acutely enhances their vasodilatory, antiinflammatory, and antioxidant action in type 2 diabetes.
Antonio Ceriello, Anna Novials, Silvia Canivell, Lucia La Sala, Gemma Pujadas, Katherine Esposito, Roberto Testa, Loredana Bucciarelli, Maurizio Rondinelli, Stefano Genovese. Diabetes Care 2014
48
50

Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia.
Piero O Bonetti, Geralyn M Pumper, Stuart T Higano, David R Holmes, Jeffrey T Kuvin, Amir Lerman. J Am Coll Cardiol 2004
664
50

Hypertension, Diabetes Type II, and Their Association: Role of Arterial Stiffness.
Harold Smulyan, Ari Lieber, Michel E Safar. Am J Hypertens 2016
37
50

Effect of vildagliptin versus glibenclamide on endothelial function and arterial stiffness in patients with type 2 diabetes and hypertension: a randomized controlled trial.
Luciana Neves Cosenso-Martin, Luiz Tadeu Giollo-Júnior, Letícia Aparecida Barufi Fernandes, Cláudia Bernardi Cesarino, Marcelo Arruda Nakazone, Maurício de Nassau Machado, Juan Carlos Yugar-Toledo, José Fernando Vilela-Martin. Acta Diabetol 2018
8
50



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.